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Phosphoenolpyruvate carboxylase (PEPC) is a tightly controlled anaplerotic enzyme situated at a
pivotal branch point of plant carbohydrate-metabolism. In developing castor oil seeds (COS) a novel
allosterically-densensitized 910-kDa Class-2 PEPC hetero-octameric complex arises from a tight
interaction between 107-kDa plant-type PEPC and 118-kDa bacterial-type PEPC (BTPC) subunits.
Mass spectrometry and immunoblotting with anti-phosphoSer451 speciﬁc antibodies established
that COS BTPC is in vivo phosphorylated at Ser451, a highly conserved target residue that occurs
within an intrinsically disordered region. This phosphorylation was enhanced during COS develop-
ment or in response to depodding. Kinetic characterization of a phosphomimetic (S451D) mutant
indicated that Ser451 phosphorylation inhibits the catalytic activity of BTPC subunits within the
Class-2 PEPC complex.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction conserved N-terminal seryl-phosphorylation domain, and that typ-Phosphoenolpyruvate (PEP) carboxylase (PEPC) is a tightly
regulated cytosolic enzyme of vascular plants and green algae that
catalyzes the irreversible b-carboxylation of PEP in the presence of
HCO3 to yield oxaloacetate and Pi. PEPC has been extensively stud-
ied with regards to its critical role in catalyzing the assimilation of
atmospheric CO2 during C4 and crassulacean acid metabolism pho-
tosynthesis [1]. Considerable attention has also been devoted to
PEPC’s essential non-photosynthetic functions, particularly the
anaplerotic replenishment of tricarboxylic-acid-cycle intermedi-
ates consumed during biosynthesis and N-assimilation [2]. To
achieve its diverse roles, plant PEPCs belong to a small multigene
family encoding several plant-type PEPCs (PTPC), as well as a dis-
tantly related bacterial-type PEPC (BTPC) isozyme [2]. PTPC genes
encode closely related 100–110-kDa polypeptides that contain achemical Societies. Published by E
from Arabidopsis thaliana; co-





).ically assemble as homotetrameric Class-1 PEPCs [1]. By contrast,
plant BTPC genes encode 116–118-kDa polypeptides that are more
comparable to prokaryotic PEPCs than to PTPCs [2]. Native PEPC
puriﬁcations from unicellular green algae and developing castor
oil seeds (COS) led to the discovery of unusual high-Mr Class-2 PEPC
heteromeric complexes composed of tightly associated PTPC and
BTPC subunits, and that are largely desensitized to allosteric effec-
tors relative to Class-1 PEPCs [3–8]. Several lines of evidence
strongly suggest that BTPCs only exist in vivo as subunits of a
Class-2 PEPC complex [6–12]. Class-2 PEPCs exhibit biphasic PEP
saturation kinetics, as both subunit types are activewithin the com-
plex. Relative to the PTPC subunits, BTPC subunits exhibit lower PEP
afﬁnity, but a higher Vmax along with remarkable insensitivity to
Class-1 PEPC allosteric inhibitors such as malate and Asp [4,10].
The BTPC subunits also function as regulatory subunits bymodulat-
ing the PEP binding, catalytic potential, and allosteric effector sen-
sitivity of associated PTPC subunits within Class-2 PEPC [7,10]. The
unusual structural, kinetic, and regulatory features of COS and
green algal Class-2 PEPCs are consistent with their putative func-
tion as a ‘metabolic overﬂow’mechanism that could maintain a sig-
niﬁcant anaplerotic ﬂux from PEP to oxaloacetate under
physiological situations that would largely inhibit Class-1 PEPC.lsevier B.V. All rights reserved.
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motif that is a hallmark of PTPCs, BTPC is in vivo phosphorylated
at multiple sites during COS development [11]. Only one of these
sites (Ser425) has been identiﬁed to date, and phosphorylation at
this site appears to cause inhibition of Class-2 PEPC’s BTPC sub-
units by increasing their Km(PEP) and sensitivity to Asp and malate
inhibition [13]. The aim of the current study was to identify and
characterize additional COS BTPC phosphorylation site(s). High
sensitivity fourier transform mass spectrometry (FT-MS) identiﬁed
Ser451 as one such novel phosphorylation site. The developmental
proﬁle of Ser451 phosphorylation was assessed using a phospho-
site speciﬁc antibody. BTPC phosphorylation at Ser451 appears to
be of regulatory signiﬁcance since the PEP saturation kinetics and
allosteric effector sensitivity of a phosphomimetic BTPC mutant
(S451D) were signiﬁcantly affected.
2. Materials and methods
2.1. Plant material, co-immunopuriﬁcation, and protein phosphatase
treatments
Castor bean plants (Ricinus communis; cv. Baker 296) were cul-
tivated, and developing COS endosperm harvested as previously
described [13]. Co-immunopuriﬁcation (co-IP) of BTPC polypep-
tides from endosperm extracts using an anti-(COS PTPC) immuno-
afﬁnity column, as well as incubation of a co-IP eluate with
exogenous k-phosphatase (New England BioLabs) were conducted
as previously described [11,13].
2.2. LC–MS/MS analysis and phosphopeptide identiﬁcation
Proteins were reduced with 10 mM dithiothreitol, alkylated
with 55 mM iodoacetamide and dialyzed against 10 mM ammo-
nium bicarbonate. Following tryptic digestion, the protein digest
was dissolved in 0.2% formic acid for LC–MS/MS analysis on the
Nano-Acquity Ultra-performance Liquid Chromatography system
(Waters, Milford, MA) coupled to a 7-tesla hybrid linear ion-trap
FT ion cyclotron resonance mass spectrometer (LTQ-FT ICR MS,
Thermo Fisher). The peptides were absorbed and subsequently re-
solved using a C18 analytical column of 1.7 lm BEH130
(100 lm  100 mm, Waters) and a 90 min gradient run from 5%
to 30% of solvent B (acetonitrile containing 0.1% formic acid), then
with 85% solvent B (ﬂow rate = 500 nl/min). MS data were acquired
by the data dependent MS/MS measurements following a full FT-
MS scan at the mass range of m/z 300–2000. Dynamic exclusion
was enabled for a period of 180 s. Phosphopeptide identiﬁcation
was performed using an in-house Mascot Server (version 2.3.0,
Matrix Science), and data interrogated using the National Center
for Biotechnology Information (NCBInr) database for viridiplantae.
The parameter settings allowed trypsin digestion for maximum
two missed cleavage sites, and a ﬁxed peptide modiﬁcation of
cysteine carbamidomethylation. Deamidation of Asn and Gln,
Met oxidation, phosphorylation of Ser, Thr, and Tyr were consid-
ered as variable modiﬁcations. Mass tolerances were set up to
10 ppm for the FT MS ions, and 1 Da for ion trap MS/MS fragment
ions. Phosphorylation sites were validated by manual inspection of
MS/MS spectra with predicted fragments.
2.3. Preparation of phosphosite speciﬁc antibodies against pSer451 of
COS BTPC and immunoblotting
Synthetic phospho- and dephospho-peptides were made corre-
sponding to the sequence ﬂanking Ser451 of COS BTPC (residues
447–457 [see Figs. 2A and 4]) with an additional cysteine at the
N-terminus (Sheldon Biotechnology Centre, McGill University,Montreal QC, Canada). Puriﬁed phosphopeptide (1 mg) was cou-
pled to maleimide-activated keyhole limpet hemocyanin (Pierce
Chemicals) according to the manufacturer’s protocols. The conju-
gate was desalted into Pi-buffered saline, ﬁlter sterilized, and
emulsiﬁed with Titermax Gold adjuvant (CytRx Corp.). Following
collection of pre-immune serum, 500 lg of phosphopeptide conju-
gate was injected subcutaneously into a New Zealand rabbit. A
250 lg booster injection was administered 30 days later. Seven
days after the ﬁnal injection, blood was collected into Vacutainer
tubes (Becton Dickinson) by cardiac puncture, and the immune
serum frozen in liquid N2 and stored at 80 C. For immunoblot-
ting, anti-(phospho-Ser451) immunoglobulin G (anti-pSer451)
was afﬁnity-puriﬁed as previously described [13]. Production of
rabbit anti-(COS BTPC)-IgG (anti-BTPC), SDS–PAGE, immunoblot-
ting, and chromogenic detection of antigenic polypeptides were
conducted as previously described [7,10]. All immunoblot results
were replicated a minimum of three times with representative re-
sults shown in the various Figs.
2.4. Site-directed mutagenesis, heterologous expression, and
puriﬁcation of recombinant PEPCs
Escherichia coli cells expressing recombinant AtPPC3R644A (an
inactive Arabidopsis PTPC isozyme or wild-type RcPPC4 (castor
BTPC) were obtained as previously described [13]. The QuikChange
site-directed mutagenesis kit (Stratagene) was used to introduce
a phosphomimetic S451D mutation into the RcPpc4 gene;
oligonucleotide primer pairs were as follows, forward 50-GAATC-
CAAGATAGGAAGATCTGATTTCCAGAAACTTCTA-30 and reverse 50-
CTAGAAGTTTCTGGAAATCAGATCTTCCTATCTTGGATT-30. A double
phosphomimetic mutant (S425D/S451D) was created by further
mutagenesis of the S425D plasmid [13] using the S451D primers.
The ampliﬁed vectors were transformed into E. coli using electro-
poration. Positive clones selected on Luria–Bertani plates contain-
ing 50 lg/ml kanamycin were further screened for the desired
mutation by restriction digestion and sequencing. The PEPC coding
portion in each plasmid from the conﬁrmed clones was sequence
veriﬁed. Puriﬁcation of heterologously expressed PEPCs was con-
ducted as previously described [10,13]. Brieﬂy, E. coli cells contain-
ing recombinant wild-type or mutant BTPCs and inactive PTPC
were lysed by passage through a French press, and the respective
lysates immediately mixed together to form stable Class-2 PEPC
complexes in vitro [10,13]. Resulting chimaeric Class-2 PEPCs were
puriﬁed using PrepEase™ His-Tagged High Yield Puriﬁcation Ni2+-
afﬁnity resin (USB Corp.) followed by Superdex-200 HR 16/60 and
Superose-6 10/300 GL gel ﬁltration FPLC (GE Biosciences) [10,13].
2.5. Enzyme and protein assays and kinetic studies
PEPC activity was assayed at 25 C by following NADH oxidation
at 340 nm using a kinetics microplate reader (Molecular Devices)
and the following optimized 200 ll assay mixture: 50 mm
Hepes-KOH (pH 8.0) containing 10% (v/v) glycerol, 10 mM PEP,
5 mM KHCO3, 10 mM MgCl2, 2 mM dithiothreitol, 0.15 mM NADH
and 5 units/ml of porcine muscle L-malate dehydrogenase (Roche).
One unit of PEPC activity equates to the production of 1 lmol of
oxaloacetate/min. Metabolite stock solutions were made equimo-
lar with MgCl2 and adjusted to pH 7.5. Protein concentrations were
determined by the Coomassie Blue G-250 dye-binding using
bovine c-globulin as the standard [13]. Kinetic parameters were
calculated using a least-squares regression computer kinetics pro-
gram as previously described [13], represent means of at least four
independent experiments, and are reproducible to within ±15%
S.E.M. of the mean value. Kinetic data were analyzed using the Stu-
dent’s t-test and deemed signiﬁcant if P < 0.02.
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3.1. BTPC phosphosite mapping
Previous studies established that the 118-kDa BTPC subunit of
COS Class-2 PEPC is subject to multi-site phosphorylation in vivo,
and speciﬁcally phosphorylated at Ser425 during COS development
[11,13]. Here, the increased resolution and sensitivity afforded by
FT-ICR-MS analysis of co-IP’d COS BTPC (93% sequence coverage)
independently corroborated the Ser425 phosphorylation site while
also identifying Ser451 as a new phosphosite (Fig. 1). Two abun-
dant phosphopeptides were identiﬁed by FT-ICR-MS in which the
intensity of peptide corresponding to residues 447–454 at m/z
501.7430 was approximately three-fold higher than that of the
peptide corresponding to residues 413–427 at m/z 736.3142
(Fig. 1A). Fragmentation of the doubly charged ion of m/z 501.74
displayed an apparent loss of phosphoric acid (H3PO4, 49m/z
units; i.e., 98 Da) resulting in a major fragment ion at m/z 452.99Fig. 1. Ultra Performance Liquid Chromatography LTQ-FT MS/MS identiﬁcation of
in vivo phosphorylation sites of 118 kDa BTPC polypeptides co-IP’d from stage VII
developing COS. (A) The extracted ion chromatograms of the phosphopeptide ions
at m/z 736.3142 and m/z 501.7430. (B) MS/MS spectrum of the doubly-charged ion
at m/z 501.74. Ser451 is phosphorylated since an abnormal mass residue of 69 Da
(dehydro-Ala) resulting from the dephosphorylated Ser was observed between the
fragments y3 and y4–18. (C) MS/MS spectrum of the doubly-charged ion at m/z
736.31. Ser425 is phosphorylated since the y series ions starting at the third C-
terminal residue (y3) all have a mass increment of 80 Da which corresponds to a
phosphate group (HPO3). The letters y and b denote C- and N-terminal fragment
ions, respectively. RT refers to LC retention time.(Fig. 1B). Analysis of the N-terminal bn and C-terminal yn ion series
of the smaller peptide (447IGRSSFQK454) revealed a 69 Da mass dif-
ference between two high-intensity fragments of y3 and y418
(Fig. 1B). This corresponds to an abnormal dehydroalanine residue
at Ser451 which results from the loss of a phosphate group from
phosphorylated serine. Likewise, MS/MS spectrum of the larger
peptide (413TTGNGSVANSSGSPR427) at m/z 736.31 displayed the
predominant C-terminal y series ions, in which a facile loss of
H3PO4 from the precursor ion (m/z 736.31 to m/z 687.57) and the
characteristic ions with a mass increase of 80 Da (phosphate group,
HPO3) starting at position y3 unambiguously identiﬁed this phos-
phorylation site as the previously established Ser425 (Fig. 1C)
[11,13].
3.2. Phosphorylation of BTPC at Ser451 is promoted during COS
development
A phosphoSer451-speciﬁc antibody (anti-pSer451) was gener-
ated using a synthetic phosphopeptide corresponding to residues
447–457 of COS BTPC (RcPPC4 [Fig. 2A]). Afﬁnity-puriﬁed anti-
pSer451 detected as little as 10 ng of the phosphopeptide, but
failed to cross-react with up to 200 ng of the corresponding
dephosphopeptide (Fig. 2B). The cross-reaction of anti-pSer451
with phosphopeptide was abolished when the dot blot was
co-incubated with 10 lg/ml of the phosphopeptide, whereas
dephosphopeptide addition partially blocked phosphopeptide
immunoreactivity (Fig. 2B). The use of anti-pSer451 for examining
in vivo BTPC phosphorylation was complemented with an afﬁnity-
puriﬁed antibody raised against recombinant COS BTPC [10]. This
latter antibody (anti-BTPC) allowed for normalization of total BTPC
on immunoblots. Results presented in Fig. 2C conﬁrmed that the
118-kDa subunit of co-IP’d BTPC from stage VII developing COS is
phosphorylated at Ser451. This is consistent with the phosphosite
prediction software NetPhos (http://www.cbs.dtu.dk/services/Net-
Phos/) which estimated Ser451 to have a high probability of
phosphorylation (0.834), relative to the adjacent Ser450 (0.074).
Anti-pSer451 speciﬁcally cross-reacted with phospho-BTPC as the
signal was eliminated by k phosphatase pre-treatment or incuba-
tion with the blocking phosphopeptide (Fig. 2C).
To assess the developmental proﬁle for Ser451 phosphorylation,
co-IP’d BTPC from COS endosperm was immunoblotted using anti-
pSer451 or anti-BTPC (Fig. 2D). Samples were loaded based on
equal amounts of 118-kDa BTPC polypeptides. The immunoblots
indicated that Ser451 phosphorylation progressively increases dur-
ing COS development, becoming maximal at stage IX (maturation
phase) (Fig. 2D). Furthermore, relative Ser451 phosphorylation
was enhanced 3 days following photosynthate elimination caused
by depodding of stage VII COS (Fig. 2D). These results parallel those
reported for the phosphorylation of BTPC at Ser425 in developing
COS [13], but contrast sharply with the in vivo phosphorylation
pattern of Class-1 PEPC’s 107-kDa PTPC subunit at Ser11 which
peaks in stage VII COS, then shows a signiﬁcant decline by stage
IX [14]. Moreover, complete in vivo PTPC dephosphorylation oc-
curred within 2 days of removal of photosynthate supply by pod
excision, concomitant with the disappearance of PTPC protein ki-
nase activity [15].
3.3. Characterization of phosphomimetic mutants indicates that
Ser451 phosphorylation inhibits BTPC activity
An E. coli lysate containing a heterologously expressed phosp-
homimetic Ser451 BTPC mutant (RcPPC4S451D) was mixed with ly-
sates containing a catalytically inactive Arabidopsis PTPC mutant
(AtPPC3R644A) to generate a stable, chimaeric Class-2 PEPC com-
plex. This approach was previously used to deduce the kinetic
inﬂuence of Ser425 BTPC phosphorylation [13] as it avoids the
Fig. 2. Immunological detection of the in vivo phosphorylation of COS BTPC at
Ser451. (A) Sequence of synthetic phosphopeptide that was used for rabbit
immunization. The sequence numbering represents amino acid position in COS
BTPC (RcPPC4). The peptide was synthesized with an extra N-terminal Cys residue
to facilitate its conjugation to keyhole limpet hemocyanin. The seryl phosphory-
lation site is indicated. (B) Dot blots of varying amounts of the synthetic
phosphopeptide and corresponding dephosphopeptide were probed with afﬁnity-
puriﬁed anti-pSer451 in the presence and absence of 10 lg/ml of dephosphopep-
tide or phosphopeptide. (C) Co-IP’d BTPC from stage VII developing COS endosperm
was incubated for 20 min with (+) and without () k-phosphatase (k-P’tase).
Samples were subjected to SDS–PAGE followed by immunoblotting with anti-BTPC
or anti-pSer451 in the presence of 10 lg/ml of dephosphopeptide or phosphopep-
tide. (D) Proﬁle of relative BTPC phosphorylation at Ser451 during COS develop-
ment, and inﬂuence of seed pod excision on this process. Co-IP’d endosperm
extracts were subjected to SDS–PAGE, and then immunoblotted with anti-pSer451
or anti-BTPC. Developmental stages V, VII, and IX correspond to the mid-cotyledon,
full cotyledon, and maturation phases of development [13]. Stems containing intact
pods of stage VII developing COS were excised and placed in water in the dark at
24 C for 72 h; ‘Depod VII’ denotes a co-IP’d endosperm extract prepared from the
excised pods of developing COS.
Table 1
PEP saturation kinetics of heterologously expressed, chimaeric Class-2 PEPC contain-
ing an inactive Arabidopsis PTPC mutant (AtPPC3R644A) and active wild-type or
phosphomimetic castor BTPC (RcPPC4S425D, S451D, and S425D/S451D) subunits. All values
represent the mean of four separate determinations and are reproducible to within
±15% S.E.M. of the mean value.









Wild-type 9.4 0.76 11 0.74
S425Da 10.9 2.7 12.4 2.0
S451D 12.5 2.4 11.7 2.1
S425D/S451D 10.0 1.6 11.2 1.0
a Data taken from O’Leary et al. [13].
Fig. 3. Inﬂuence of L-malate and L-aspartate on the activity of phosphomimetic
BTPC mutants. Shown are the I50(malate) (A) or I50(Asp) (B) values for heterolo-
gously expressed Class-2 PEPC complexes containing an inactive PTPC mutant
(AtPPC3R644A) and either a wild-type (wt) or phosphomimetic castor BTPC
(RcPPC4S425D, S451D, and S425D/S451D) subunits. PEPC activity was determined at pH
7.0 with subsaturating PEP (1 mM). All values represent the means ± S.E.M. of at
least four independent determinations. Results for S425D were taken from O’Leary
et al. [13]. Asterisks denote values that are signiﬁcantly different from wild-type
(P < 0.02, Students’ t-test).
1052 K.J. Dalziel et al. / FEBS Letters 586 (2012) 1049–1054complicating effect of having simultaneously active PTPC and BTPC
subunits within the Class-2 PEPC. A double phosphomimetic BTPC
mutant (RcPPC4S425D/S451D) was also created which contained both
the S425D and S451D mutations. Recombinant chimaeric Class-2
PEPCs were puriﬁed to near homogeneity by nickel afﬁnity and
gel ﬁltration FPLC (Supplementary Fig. 1). They all eluted from
the ﬁnal gel ﬁltration column as stable Class-2 PEPC hetero-
octameric complexes of 900 kDa (results not shown).
Kinetic properties of the single S451D and double S425D/S451D
BTPC phosphomimetic mutants were compared to wild-type BTPC,
as well as the previously described S425D BTPC mutant. The S425D
and S451D single mutations both caused an approximate three-
fold increase in BTPC’s Km(PEP) at optimal and suboptimal pH
(8.0 and 7.3, respectively), without signiﬁcantly altering Vmax
(Table 1). The kinetic inﬂuence of several allosteric effectors of
non-photosynthetic PEPCs [2] was examined at pH 7.0 and subsat-
urating (1 mM) PEP. The following compounds (5 mM each) hadlittle to no inﬂuence (±15% of control activity) on wild-type or
mutant BTPC activity: Glc-6-P, Glc-1-P, Fru-6-P, glycerol-3-P, and
Glu. However, the S425D and S451Dmutations both elicited signif-
icant reductions in BTPC’s I50(malate) and I50(Asp) values (Fig. 3).
No difference in the pH–activity proﬁle of the S451D mutant was
noted relative to wild-type BTPC (Supplementary Fig. 2).
Interestingly, the double S425D/S451D phosphomimetic muta-
tions appeared to cause a less pronounced inhibition of BTPC cata-
lytic activity relative to either of the respective single mutations
(Table 1, Fig. 3). As no structural data is available for castor BTPC,
it is difﬁcult to envision what type of interaction might occur be-
tween these two Asp residues to account for this attenuation of
inhibition. Although Asp simulates phosphoSer both by its negative
charge as well as its space ﬁlling properties, phosphomimetics
should be interpreted with caution as structural and/or kinetic ef-
fects arising from Ser to Asp substitutions do not always parallel
those brought about by Ser phosphorylation [16,17]. The solution
lies in detailed comparative studies of monophosphorylated
(pS425 or pS451) and the corresponding diphosphorylated
(pS425/pS451) versions of castor BTPC catalytic subunits within
the Class-2 PEPC complex. Unfortunately, native Class-2 PEPC con-
taining non-degraded, in vivo multisite phosphorylated BTPC sub-
units cannot be isolated from developing COS owing to the BTPC’s
marked susceptibility to proteolytic cleavage by an endogenous
thiol endopeptidase [7,8]. Thus, work is in progress to identify
endogenous COS or exogenous protein kinases that catalyze site-
speciﬁc phosphorylation of heterologously-expressed castor BTPC
Fig. 4. Alignment of COS BTPC’s Ser425 and Ser451 phosphorylation domain with other vascular plant BTPCs. Partial BTPC amino acid sequences were aligned with MEGA
(ver. 5.05) using the MUSCLE algorithm with default settings [19]. The alignment was formatted for display in Jalview (ver. 2.7; http://www.jalview.org/), with residues
shaded based on conservation. The protein sequences were identiﬁed using NCBI’s BLAST program and the NCBI (www.ncbi.nlm.nih.gov/) or Phytozome (www.phyto-
zome.org) databases.
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establish the role that multisite BTPC phosphorylation plays in
the in vivo control of Class-2 PEPC activity and anaplerotic C-ﬂux
in developing COS.
4. Concluding remarks
Results presented in this study corroborate our earlier report
that BTPC subunits of Class-2 PEPC are subject to multisite phos-
phorylation in developing COS endosperm [11,13], while establish-
ing Ser451 as a novel in vivo phosphorylation site. The combined
results indicate that similar to phosphorylation of COS BTPC at
Ser425 (Table 1, Fig. 3) [13]: (i) BTPC is subject to regulatory inhibi-
tion when phosphorylated at Ser451; and (ii) Ser451 phosphoryla-
tion stoichiometry increases during COS development or following
COS depodding. It is reasonable to assume that COS depodding or
the ﬁnal stages of COS development both coincide with a reduced
ﬂux of PEP through the anaplerotic PEPC reaction to storage end-
products. Attenuation of overall PEPC activity could be mediated
by enhanced phosphorylation of Class-2 PEPC’s BTPC subunits at
Ser425 and Ser451, coupled with the simultaneous dephosphoryla-
tion of the Class-1 PEPC’s PTPC subunits at Ser11 [13–15].
Alignment of deduced BTPC sequences from various plant spe-
cies places Ser425 and Ser451 in a particularly divergent domain
comprised of approximately 150 amino acids (corresponding to
residues 316–466 of castor BTPC [RcPPC4]), a unique structural
feature of BTPCs [2]. Secondary structure analysis predicted that
this region exists in a largely unstructured and ﬂexible conforma-
tion known as an intrinsically disordered domain [12,13]. In con-
trast to the Pro-directed (at position P+1) Ser425 phosphosite
[2,11,13], the sequence ﬂanking Ser451 at positions P2 and P+3
corresponds to a basophilic kinase motif that is somewhat reminis-
cent of a sucrose non-fermenting-1-related protein kinase (SnRK1)
recognition element (Fig. 4). SnRK1s play a crucial role in coordi-
nating C- and N-metabolism in plant storage organs and have a
minimal recognition motif generally given as a Ser or Thr residue
with basic residues at positions P6 and P3, and hydrophobic
residues at positions P5 and P+4 [18]. Relative to Ser451, COS
BTPC has a basic Arg residue at position P2 and hydrophobic res-
idues at positions P4 and P+4 (Ile and Leu, respectively) (Fig. 4).
Sequence alignment revealed that Ser451, as well as the basic res-
idue at P2, and hydrophobic residues at positions P4 and P+4are highly conserved in orthologous vascular plant BTPC
sequences. The apparent exceptions are the conservative Ser to
Thr substitutions in Glycine max (soybean) and Picea sitchensis
(sitka spruce) BTPCs (Fig. 4). Given that the Ser451 phosphoryla-
tion site is conserved amongst several BTPC orthologs, along with
that of Ser425 to a lesser degree (Fig. 4), it will be important to
establish the extent to which BTPC is subject to regulatory phos-
phorylation in other plant species. It will also be of interest to iden-
tify and characterize the COS protein kinases that mediate in vivo
BTPC phosphorylation at Ser425 and Ser451, as well as to docu-
ment the nature of the upstream signaling pathways.
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